The report covers forecast and analysis for the metabolomics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.
The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market.
Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.
This report segments for metabolomics market as follows:
Metabolomics Market: Technology Segment Analysis
- High performance liquid chromatography
- Mass spectrometry
- Capillary electrophoresis
- Gas chromatography
- Nuclear magnetic resonance spectroscopy
Metabolomics Market: Indication Segment Analysis
Metabolomics Market: Application Segment Analysis
- Drug discovery
- Danaher Corporation
- Bruker Corporation
- Waters Corporation
- Metabolon, Inc.
- Agilent Technologies
- Thermo Fisher Scientific
- Shimadzu Corporation
For more information visit http://www.researchandmarkets.com/research/wkgfpj/metabolomics
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-metabolomics-market-2021---technology-indication-for-drug-discovery-biomarker-and-nutrigenomics---research-and-markets-300312503.html
SOURCE Research and Markets